Home|Journals|Articles by Year|Audio Abstracts
 

Research Article

ECB. 2021; 10(3): 179-185


NITROGEN RICH IMIDAZOLE-TRIAZOLOPYRIMIDINE HYBRIDS: CATALYST FREE SYNTHESIS, ANTIMICROBIAL and ANTITUBERCULAR STUDIES

Panchani N.M., Joshi H.S.




Abstract

Herein we have reported a simple, rapid and efficient synthesis of 7-(substituted phenyl)-5-(1H-imidazol-4-yl)-5,8-dihydro-[1,2,4]triazolo[4,3-a]pyrimidine derivatives. In the present study, PEG-400 was used as an alternative and green reaction solvent in the first step and n-butanol in the second step. The protocol proposed in this work offers advantages, such as common starting materials, simple work-up, shorter reaction time, high yield and absence of the catalyst. The structural elucidation of these compounds is based on mass, IR, 1H NMR and 13C NMR spectral data. All the synthesized compounds have been evaluated for their in vitro antimicrobial and antitubercular activity.

Key words: Absence of catalyst; Antitubercular activity; Imidazole; Pyrimidine; Triazole






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.